Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone and Berberine in NAFLD with IGR or T2DM
NCT00633282Phase 2Completed
- Start
- Mar 2008
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pioglitazone, berberine in non-alcoholic fatty liver disease (NAFLD). Started Mar 2008; status: completed.
02
Drugs
pioglitazoneberberine
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT00633282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00633282.